Clinical Trials Browser

Unknown × Interventional × acalabrutinib × Clear all

NCT03736616 2022-07-22

Acalabrutinib Plus RICE for Relapsed/Refractory DLBCL

Phase 2 Unknown

Lymphoma, Large B-Cell, Diffuse